Transforming Growth Factor Beta 1 (TGF B1)

Last Modified: 11/23/2022 2:28:44 PM


Medical Necessity Documentation:  
Client Notes:  
Patient Preparation:  
Specimen Requirements: 1.0 mL Frozen Plasma from a Lavender Top Tube - EDTA in a Plastic Vial
Collection Instructions: Remove plasma from cells within 30 minutes of collection: 
Centrifuge for 15 minutes at 1000XG within 30 minutes of collection. 
Centrifuge plasma again at 3000XG for complete platelet removal.
Freeze
Minimum Volume: 0.25 mL Plasma
Transport & Storage: Temperature/Stability: Frozen
Rejection Criteria: Hemolysis • Gross lipemia • Specimens with particulate matter or microbial contamination • Specimens outside of listed stability
Reference Range:

Refer to Interpretive Results
Critical Ranges:  
Test Comments:  
Methodology: Enzyme-Linked Immunosorbent Assay (ELISA)
Clinical Significance: Transforming Growth Factor (TGF) plays a crucial role in tissue regeneration, cell differentiation, embryonic development, and regulation of the immune system. Transforming growth factor beta is found in hematopoietic (Blood-forming) tiisue and initiates a signaling pathway that supresses the early development of cancer cells. It enhances the deposition of extracellular matrix and may play potential role in wound healing and cirrhosis formation. Many cells synthesis TGF-b and almost all of them have specific receptors for this peptide
Documentation:  
Custom Panel: No

PRODUCTION SCHEDULE

Days Performed: Monday
Sites Performed: Quest - Chantilly to Cambridge Medical
PHL Test Code: MSOT
EPIC Test Code:
Send Out Test Code: 91238
Alternate Test Names: Human Transforming Growth Factor beta 1 (TGF-b1); TGF B 1; Transforming Growth Factor beta
Included Tests:  
CPT Coding: 83520

Go back to the top of the page.